Lucky for Teva Pharmaceuticals, interest rates on all kinds of debt have never been lower in recorded human history, and they keep getting lower even beyond basic logic.
June 24, 2016: Here are four stocks trading with heavy volume among 119 equities making new 52-week lows in Friday’s session. NYSE decliners led advancers by more than 4 to 1 and…
June 23, 2016: Here are four stocks trading with relatively heavy volume among 18 equities making new 52-week lows in Thursday’s session. NYSE advancers led decliners by 4 to 1 and Nasdaq…
June 21, 2016: Here are four stocks trading with relatively heavy volume among 50 equities making new 52-week lows in Tuesday’s session. NYSE advancers led decliners by 5 to 4 while Nasdaq…
June 20, 2016: Here are four stocks trading with relatively heavy volume among 20 equities making new 52-week lows in Monday’s session. NYSE advancers led decliners by 4 to 1 while Nasdaq…
With second-quarter earnings right around the corner, you can bet many of the corporate executives and 10% owners are looking to add shares before trading windows close.
June 17, 2016: Here are four stocks trading with relatively heavy volume among 36 equities making new 52-week lows in Friday’s session. NYSE advancers led decliners by less than 3 to 2…
June 16, 2016: Here are four stocks trading with relatively heavy volume among 74 equities making new 52-week lows in Thursday’s session. NYSE advancers and decliners were approximately equal for the day while Nasdaq decliners…
Biotech companies that lost their way last week truly burned shareholders, whether it was due to ASCO, earnings or even unfavorable clinical trial updates.
Despite its track record, some analysts are calling for an inflection point, while others are taking a relatively neutral stance on Valeant Pharmaceuticals.
Chris Lange June 7, 2016: Here are four stocks trading with relatively heavy volume among 13 equities making new 52-week lows in Tuesday’s session. NYSE advancers led decliners by less than 2 to 1…
Valeant Pharmaceuticals International reported disappointing first-quarter financial results before the markets opened on Tuesday.
Chris Lange 24/7 Wall St. has put together a preview of Lululemon Athletica and a few other major companies reporting their quarterly results this week.
Here are four biotech companies that have just either closed fresh financing rounds or issued IPOs that exceeded price expectations.
Valeant Pharmaceuticals is trying to change its tune by announcing that it will offer an enhanced rebate program to all hospitals in the United States, in an effort to reduce the price…
Chris Lange 
